Biotica becomes new victim of Pfizer’s R&D downsizing
August 8, 2011Research and Development, Sales and Marketing
Pfizer has pulled out of a $195 million deal with UK firm Biotica, as it continues to downsize its global …
Meet Wainwright Associates at the TOPRA Symposium and CPhl worldwide
August 7, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates
Wainwright Associates is an independent company offering consultancy services to the pharmaceutical, medical device and healthcare industry in Product Development, …
Dissent over patient involvement reforms
August 5, 2011Medical Communications HealthWatch, NHS, patient involvement
The first 75 ‘pathfinders’ have been named in Local HealthWatch, the patient representative organisations due to replace the current local …
Gilenya rejected by NICE
August 5, 2011Medical Communications, Sales and Marketing MS, NICE, Novartis, gilenya
NICE has not recommended Novartis’ multiple sclerosis drug Gilenya because of its cost and ‘uncertainties over its clinical effectiveness’. Gilenya …
First personalised asthma drug shows promise
August 4, 2011Roche, asthma, personalised medicine
Roche’s personalised asthma drug lebrikizumab has met its primary end point in a phase II trial. Lebrikizumab increased the level …
NHS must personalise services for long-term conditions
August 3, 2011Sales and Marketing NHS, long term conditions
The government is highlighting a scheme in West Yorkshire as providing a way forward for reducing the cost burden on …
Mergers and spending cuts damaging drug research
August 3, 2011Research and Development, Sales and Marketing LaMattina, Pfizer, research productivity
Big pharma’s policy of mergers and swingeing cuts is having a devastating effect on drug research, says a former Pfizer …
SHL to Speak and Exhibit at the World Drug Delivery Congress 2011
August 3, 2011Manufacturing and Production auto injector, autoinjector, drug delivery, imapac, shl group
With the increasing number of biologics coming to market, the demand for drug delivery solutions such as auto injectors has …
Pfizer looks to spin off animal health and nutrition
August 2, 2011Sales and Marketing Pfizer, Q2, animal health, divestment, nutrition
Pfizer looks set to spin-off or sell its animal health and nutrition business units in order to focus on human …
Fujifilm plans generic venture with Dr. Reddy’s
August 2, 2011Manufacturing and Production Dr Reddy's, Fujifilm
Japanese photography and imaging company Fujifilm has taken another step into the healthcare sector with a new joint venture with …
Actelion’s MS candidate shows promise
August 2, 2011Research and Development Actelion, MS
Actelion’s prospective multiple sclerosis pill ponesimod has cheered the company by meeting its primary endpoint in a phase IIb trial. …
US debt deal could hit pharma
August 2, 2011Sales and Marketing Obama, PhRMA, US, healthcare reform
The deal to raise America’s debt ceiling could have long-term consequences for the US pharma industry. The tense stand-off between …
Teva’s MS treatment disappoints
August 2, 2011Research and Development, Sales and Marketing Laquinimod, MS, Teva
Teva and Active Biotech’s oral MS drug laquinimod has failed to meet its primary endpoint in a phase III trial. …
Merck vaccines contaminated with plastic, says FDA
August 2, 2011Manufacturing and Production Contamination, Merck & Co, vaccines
Vaccines made by Merck & Co at its West Point facility in Philadelphia, US, have been found to be contaminated …
Quintiles launches first salesforce in Russia
August 2, 2011Sales and Marketing CSO, Quintiles, Russia, emerging markets
Quintiles is set to launch its first contract sales project in Russia with a 40 strong sales team. The company …
Daiichi Sankyo Selects Veeva CRM to Support Customer Engagement Initiatives in the UK
August 1, 2011BARCELONA, SPAIN and GERRARDS CROSS, BUCKS, UK – 26 July, 2011 – Veeva Systems announced today that Daiichi Sankyo, one …
T Wave Indices of Drug Induced Changes in Repolarisation
August 1, 2011For the past decade prolongation of the QT interval has been used by the regulatory agencies as the principal biomarker …
Once daily Viramune set for approval in Europe
August 1, 2011Sales and Marketing Boehringer Ingelheim, HIV
European regulators have recommended the approval of a new, once-daily form of Boehringer Ingelheim’s HIV treatment Viramune. Viramune (nevirapine) has …
FDA refuses to file Eisai’s epilepsy drug
August 1, 2011Sales and Marketing Eisai, FDA, epilepsy
The FDA has refused to file Eisai’s epilepsy drug perampanel, saying it needs more information for the treatment. The FDA …
Merck KGaA appoints Udit Batra
August 1, 2011Sales and Marketing appointment, sales and marketing
Udit Batra is to join Merck KGaA as head of its consumer health care division on 1 September. He moves …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
